Literature DB >> 1899869

Nuclear targeting of prothymosin alpha.

R E Manrow1, A R Sburlati, J A Hanover, S L Berger.   

Abstract

Prothymosin alpha is a highly acidic protein which lacks an amino-terminal signal peptide, yet was once thought to be a precursor for thymosin alpha 1, a putative peptide hormone secreted by the thymus. Here, two lines of evidence are presented that strongly implicate prothymosin alpha as a nuclear protein: 1) in COS cells transfected with the human prothymosin alpha gene copious amounts of prothymosin alpha were present in sealed nuclei obtained by treating these cells with cytochalasin B and enucleating them centrifugally. 2) Constructs in which human prothymosin alpha nucleic acid sequences were fused in-frame either near the amino terminus of the beta-galactosidase gene in pCH110 or at the carboxyl terminus, when expressed in COS cells, resulted in nuclear localization of the fusion protein; indirect immunofluorescence in situ was used as the assay. The basic cluster of amino acids at the carboxyl terminus of prothymosin alpha, TKKQKT, has been identified as part of the nuclear targeting signal, whereas the basic cluster of amino acids situated within the thymosin alpha 1 sequence at the amino terminus failed to effect nuclear transport.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899869

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Properties of the protein kinase that phosphorylates prothymosin alpha.

Authors:  A Peréz-Estévez; J Freire; C Sarandeses; G Covelo; C Díaz-Jullien; M Freire
Journal:  Mol Cell Biochem       Date:  2000-05       Impact factor: 3.396

2.  Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.

Authors:  M A Cotter; E S Robertson
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

3.  Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity.

Authors:  P G Martini; R Delage-Mourroux; D M Kraichely; B S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Evidence for the extranuclear localization of thymosins in thymus.

Authors:  O E Tsitsiloni; P P Yialouris; H Echner; W Voelter; A A Haritos
Journal:  Experientia       Date:  1992-04-15

5.  Evidence for nuclear targeting of prothymosin and parathymosin synthesized in situ.

Authors:  M Clinton; L Graeve; H el-Dorry; E Rodriguez-Boulan; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

6.  Overexpression of prothymosin alpha accelerates proliferation and retards differentiation in HL-60 cells.

Authors:  P Rodríguez; J E Viñuela; L Alvarez-Fernández; M Buceta; A Vidal; F Domínguez; J Gómez-Márquez
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

7.  Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes.

Authors:  Ruben N Karapetian; Alexandra G Evstafieva; Irina S Abaeva; Nina V Chichkova; Grigoriy S Filonov; Yuri P Rubtsov; Elena A Sukhacheva; Sergey V Melnikov; Ulrich Schneider; Erich E Wanker; Andrey B Vartapetian
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

8.  Prothymosin alpha modulates the interaction of histone H1 with chromatin.

Authors:  Z Karetsou; R Sandaltzopoulos; M Frangou-Lazaridis; C Y Lai; O Tsolas; P B Becker; T Papamarcaki
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

9.  An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc.

Authors:  S Gaubatz; A Meichle; M Eilers
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Deletion of Nuclear Localizing Signal Attenuates Proinflammatory Activity of Prothymosin-Alpha and Enhances Its Neuroprotective Effect on Transient Ischemic Stroke.

Authors:  Liang-Chao Wang; Chao-Liang Wu; Ya-Yun Cheng; Kuen-Jer Tsai
Journal:  Mol Neurobiol       Date:  2016-01-09       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.